Fresenius SE & Co. KGaA buy dokem
Start price
02.07.17
/
50%
€75.41
Target price
02.01.18
€79.70
Performance (%)
-13.71%
End price
02.01.18
€65.07
Summary
This prediction ended on 02.01.18 with a price of €65.07. The price of Fresenius SE & Co. KGaA has decreased during the runtime of the prediction. Compared to the start price this resulted in a performance of -13.71%. dokem has 50% into this predictionFresenius is a German healthcare company listed on the Frankfurt and New York stock exchanges under the symbol FSNUF. The company is primarily engaged in the production and distribution of medical devices, pharmaceuticals, and services related to renal dialysis, critical care, and hospital operations. With over 290,000 employees and operations in more than 100 countries, Fresenius is one of the largest healthcare providers in the world. The company has experienced steady growth over the years, driven by its innovative product portfolio, strategic acquisitions, and a focus on operational efficiency.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Fresenius SE & Co. KGaA | 1.776% | 1.776% | 4.930% | -33.378% |
| iShares Core DAX® | -3.033% | -0.013% | 11.953% | 15.609% |
| iShares Nasdaq 100 | -3.554% | -2.546% | 30.128% | 44.540% |
| iShares Nikkei 225® | -3.938% | 2.183% | 11.741% | 8.345% |
| iShares S&P 500 | -1.517% | -0.882% | 25.752% | 42.388% |
Comments by dokem for this prediction
In the thread Fresenius SE & Co. KGaA diskutieren
dokem stimmt der Buy-Einschätzung von melinda zu
dokem stimmt am 01.07.2017 der Buy-Einschätzung von melinda mit dem Kursziel 79€ zu.Überschrift: a suivre
(Laufzeit überschritten)